The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
Open accessAbstract
BACKGROUND: In Thailand, phase 1/2 trials of monovalent subtype B and bivalent subtype B/E (CRF01_AE) recombinant glycoprotein 120 human immunodeficiency virus type 1 (HIV-1) vaccines were successfully conducted from 1995 to 1998, prompting the first HIV-1 vaccine efficacy trial in Asia. METHODS: This randomized, double-blind, placebo-controlled efficacy trial of AIDSVAX B/E (VaxGen), which included 36-months of follow-up, was conducted among injection drug users (IDUs) in Bangkok, Thailand. The primary end point was HIV-1 infection; secondary end points included plasma HIV-1 load, CD4 cell count, onset of acquired immunodeficiency syndrome-defining conditions, and initiation of antiretroviral therapy. RESULTS: A total of 2546 IDUs were enrolled between March 1999 and August 2000; the median age was 26 years, and 93.4% were men. The overall HIV-1 incidence was 3.4 infections/100 person-years (95% confidence interval [CI], 3.0-3.9 infections/100 person-years), and the cumulative incidence was 8.4%. There were no differences between the vaccine and placebo arms. HIV-1 subtype E (83 vaccine and 81 placebo recipients) accounted for 77% of infections. Vaccine efficacy was estimated at 0.1% (95% CI, -30.8% to 23.8%; P=.99, log-rank test). No statistically significant effects of the vaccine on secondary end points were observed. CONCLUSION: Despite the successful completion of this efficacy trial, the vaccine did not prevent HIV-1 infection or delay HIV-1 disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
Robinson, W. E., Montefiori, D., & Mitchell, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91657-1 · Cited by 358
Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V., Self, S. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428405 · Cited by 355
Self-citationAntibody-Dependent Enhancement of Infection and the Pathogenesis of Viral Disease
Morens, D. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.3.500 · Cited by 317
Exposure stratified case-cohort designs.
Borgan, Ø., Langholz, B. M., Samuelsen, S. O., Goldstein, L. J., & Pogoda, J. M. (2000) · Lifetime Data Analysis · doi:10.1023/a:1009661900674 · Cited by 286
Genetic Variants of HIV-1 in Thailand
McCUTCHAN, F. E., HEGERICH, P. A., BRENNAN, T. P., PHANUPHAK, P., SINGHARAJ, P., JUGSUDEE, A., BERMAN, P. W., GRAY, A. M., FOWLER, A. K., & BURKE, D. S. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1887 · Cited by 250
Fultz, P. N., Nara, P., Barre-Sinoussi, F., Chaput, A., Greenberg, M. L., Muchmore, E., Kieny, M.-P., & Girard, M. (1992) · Science · doi:10.1126/science.256.5064.1687 · Cited by 160
Vanichseni, S., Kitayaporn, D., Mastro, T. D., Mock, P. A., Raktham, S., Jarlais, D. C. D., Sujarita, S., Srisuwanvilai, L.-O., Young, N. L., Wasi, C., et al. (2001) · AIDS · doi:10.1097/00002030-200102160-00013 · Cited by 147
Self-citationEstimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.
Mastro, T. D., Kitayaporn, D., Weniger, B. G., Vanichseni, S., Laosunthorn, V., Uneklabh, T., Uneklabh, C., Choopanya, K., & Limpakarnjanarat, K. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.7.1094 · Cited by 145
Self-citationViral load differences in early infection with two HIV-1 subtypes
Hu, D. J., Vanichseni, S., Mastro, T. D., et al. (2001) · AIDS · doi:10.1097/00002030-200104130-00003 · Cited by 110
Self-citationMascola, J. R., Mathieson, B. J., Zack, P. M., Walker, M. C., Halstead, S. B., & Burke, D. S. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1175 · Cited by 96
(1997) · PsycEXTRA Dataset · doi:10.1037/e547572006-001 · Cited by 83
MacQueen, K. M., Vanichseni, S., Kitayaporn, D., Lin, L. S., Buavirat, A., Naiwatanakul, T., Raktham, S., Mock, P. A., Heyward, W. L., Jarlais, D. C. D., et al. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199907010-00010 · Cited by 79
Self-citationAdvancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
Francis, D. P., Gregory, T. J., McElrath, M. J., Belshe, R. B., Gorse, G. J., Migasena, S., Kitayaporn, D., Pitisuttitham, P., Matthews, T. J., Schwartz, D. H., et al. (1998) · PubMed · Cited by 73
Gilbert, P. B., Ackers, M., Berman, P. W., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/432734 · Cited by 72
Self-citationVongchak, T., Kawichai, S., Sherman, S. G., Celentano, D. D., Sirisanthana, T., Latkin, C. A., Wiboonnatakul, K., Srirak, N., Jittiwutikarn, J., & Aramrattana, A. (2005) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2004.11.003 · Cited by 69
Thailand: lessons from a strong national response to HIV/AIDS.
Phoolcharoen, W., Ungchusak, K., Sittitrai, W., & Brown, T. (1998) · PubMed · Cited by 56
Simultaneous Inferences on the Contrast of Two Hazard Functions with Censored Observations
Gilbert, P. B., Wei, L. J., Kosorok, M. R., & Clemens, J. D. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00773.x · Cited by 49
Self-citationWas the 1988 HIV epidemic among Bangkokʼs injecting drug users a common source outbreak?
Wright, N. H., Vanichseni, S., Akarasewi, P., Was, C., & Choopanya, K. (1994) · AIDS · doi:10.1097/00002030-199404000-00017 · Cited by 43
Self-citationvan Griensven, F., Pitisuttithum, P., Vanichseni, S., et al. (2005) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2005.02.003 · Cited by 21
Self-citationGorse, G. J., Patel, G. B., Newman, F. K., Belshe, R. B., Berman, P. W., Gregory, T. J., & Matthews, T. J. (1996) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.4.378-386.1996 · Cited by 10
Cited by
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Self-citationChoopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Self-citationSanders, R. W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Peña, A. T., Korzun, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003618 · Cited by 935
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O. D., Carter, D. K., Hural, J., Akondy, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 713
Metadata
- Authors
- Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-12-15
- Volume
- 194
- Issue
- 12
- Pages
- 1661-1671
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2152640863
- Cited by
- 847
- References
- 21
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.